Nifty

:

25461.00

Sensex

:

83432.89

55.70 (0.22%)
193.42 (0.23%)

Login

Nifty
Sensex

:
:

25461.00
83432.89

55.70 (0.22%)
193.42 (0.23%)

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

64/99

BSE: 539730 | NSE: Not Listed

Watchlist

NSE BSE

807.30

04-Jul-2025

Open
High
Low
Previous Close

819
819
800
813.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

15018
12142971
819
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

381.18
18.32
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

542.77
0.09%
2.70

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.96
25.29
15.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

36.76
35.46
22.26

PAT CAGR (%)

10 Years
5 Years
3 Years

50.62
52.40
35.06

P:E (Median)

8 Years
5 Years
3 Years

40.97
45.66
29.59

P:BV (Average)

8 Years
5 Years
3 Years

3.93
4.11
4.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.89
18.85
16.15

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 167.41 118.03 41.84% 102.70 87.01 18.03% 107.35 81.98 30.95% 78.81 62.05 27.01%
Expenses 149.97 106.87 40.33% 89.47 76.49 16.97% 93.40 72.38 29.04% 68.33 54.44 25.51%
EBITDA 17.44 11.17 56.13% 13.23 10.52 25.76% 13.95 9.61 45.16% 10.48 7.61 37.71%
EBIDTM 10.42% 9.46% 12.88% 12.09% 13.00% 11.72% 13.30% 12.26%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 8.15 4.37 86.50% 5.00 3.77 32.63% 5.31 2.90 83.10% 3.91 2.61 49.81%
Depreciation 1.25 0.96 30.21% 1.09 0.99 10.10% 1.06 0.94 12.77% 1.05 0.92 14.13%
PBT 8.04 5.84 37.67% 7.13 5.76 23.78% 7.58 5.77 31.37% 5.52 4.08 35.29%
Tax 0.97 0.78 24.36% 1.80 1.54 16.88% 3.30 1.83 80.33% 1.39 1.68 -17.26%
PAT 7.07 5.06 39.72% 5.33 4.22 26.30% 4.27 3.94 8.38% 4.13 2.40 72.08%
PATM 4.22% 4.29% 5.19% 4.85% 3.98% 4.80% 5.24% 3.87%
EPS 15.05 10.77 39.74% 11.35 8.98 26.39% 9.09 8.38 8.47% 8.79 5.11 72.02%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 167.41 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 150.16 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 17.25 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 10.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 8.15 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 1.84 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 7.26 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 1.26 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 6.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 3.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 12.71 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 456.27 348.16 274.68 224.46 133.89 112.77 97.02 59.55 56.70 42.32 25.33 Net Sales Growth 30.71% 26.75% 22.37% 67.65% 18.73% 16.23% 62.92% 5.03% 33.98% 67.07% Cost Of Goods Sold 330.03 261.32 208.68 177.10 102.25 81.75 59.88 39.51 24.57 19.04 15.31 Gross Profit 126.24 86.83 65.99 47.35 31.65 31.02 37.14 20.04 32.12 23.29 10.02 GP Margin 27.67% 24.94% 24.02% 21.10% 23.64% 27.51% 38.28% 33.65% 56.65% 55.03% 39.56% Total Expenditure 401.17 310.17 246.90 210.55 124.55 104.44 86.99 53.84 53.37 38.42 23.67 Power & Fuel Cost - 4.47 3.37 3.49 2.94 3.10 2.75 1.60 1.64 1.17 0.84 % Of Sales - 1.28% 1.23% 1.55% 2.20% 2.75% 2.83% 2.69% 2.89% 2.76% 3.32% Employee Cost - 12.50 11.54 10.66 8.66 8.95 8.04 5.19 4.92 3.83 3.22 % Of Sales - 3.59% 4.20% 4.75% 6.47% 7.94% 8.29% 8.72% 8.68% 9.05% 12.71% Manufacturing Exp. - 10.34 7.24 4.41 3.13 3.58 4.03 1.21 15.32 9.47 0.70 % Of Sales - 2.97% 2.64% 1.96% 2.34% 3.17% 4.15% 2.03% 27.02% 22.38% 2.76% General & Admin Exp. - 15.85 10.81 8.72 5.47 5.19 7.13 3.57 3.34 1.93 1.72 % Of Sales - 4.55% 3.94% 3.88% 4.09% 4.60% 7.35% 5.99% 5.89% 4.56% 6.79% Selling & Distn. Exp. - 5.07 4.24 5.61 1.77 1.76 2.59 2.54 3.46 2.71 1.64 % Of Sales - 1.46% 1.54% 2.50% 1.32% 1.56% 2.67% 4.27% 6.10% 6.40% 6.47% Miscellaneous Exp. - 0.62 1.00 0.56 0.33 0.11 2.57 0.21 0.11 0.27 1.64 % Of Sales - 0.18% 0.36% 0.25% 0.25% 0.10% 2.65% 0.35% 0.19% 0.64% 0.95% EBITDA 55.10 37.99 27.78 13.91 9.34 8.33 10.03 5.71 3.33 3.90 1.66 EBITDA Margin 12.08% 10.91% 10.11% 6.20% 6.98% 7.39% 10.34% 9.59% 5.87% 9.22% 6.55% Other Income 0.00 0.92 1.82 1.63 1.40 0.52 0.58 0.16 1.91 0.86 0.49 Interest 22.37 13.65 9.28 4.78 4.37 4.47 3.12 1.95 1.87 2.06 1.05 Depreciation 4.45 3.80 2.81 2.16 2.00 1.88 1.33 1.29 1.14 0.80 0.55 PBT 28.27 21.45 17.51 8.60 4.37 2.49 6.16 2.64 2.23 1.90 0.55 Tax 7.46 5.83 6.70 2.26 1.19 0.59 1.70 0.89 0.80 0.77 0.26 Tax Rate 26.39% 27.18% 38.26% 26.28% 37.07% 23.69% 27.60% 33.71% 35.87% 41.85% 50.00% PAT 20.80 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 PAT before Minority Interest 20.80 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.56% 4.49% 3.94% 2.82% 1.50% 1.68% 4.60% 2.94% 2.52% 2.53% 1.03% PAT Growth 33.16% 44.50% 70.50% 215.42% 5.79% -57.40% 154.86% 22.38% 33.64% 311.54% EPS 44.26 33.23 23.00 13.49 4.28 4.04 9.49 3.72 3.04 2.28 0.55

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.47 96.38 68.06 43.07 41.32 38.99 22.16 7.26 3.96 3.08 Share Capital 4.70 4.53 4.43 3.99 3.99 3.99 3.43 4.87 2.62 2.62 Total Reserves 115.20 83.52 63.42 39.08 37.33 35.00 18.74 2.39 1.34 0.46 Non-Current Liabilities 19.30 21.25 45.18 32.09 14.07 12.51 4.06 8.37 7.31 3.69 Secured Loans 12.80 15.44 42.04 29.11 11.50 10.64 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.24 6.19 2.94 Long Term Provisions 2.37 1.96 1.71 1.60 1.63 1.08 3.25 0.28 0.43 0.21 Current Liabilities 166.83 139.66 73.75 86.46 85.99 53.41 53.04 40.47 31.93 16.22 Trade Payables 62.95 59.34 48.62 59.96 46.22 33.70 38.92 22.83 16.27 6.99 Other Current Liabilities 11.59 8.31 11.62 14.84 13.79 8.94 1.33 7.75 7.18 2.82 Short Term Borrowings 86.76 67.71 10.72 10.53 23.41 8.63 9.90 7.58 6.85 5.10 Short Term Provisions 5.54 4.29 2.79 1.13 2.57 2.13 2.89 2.31 1.62 1.31 Total Liabilities 307.60 257.29 186.99 161.62 141.38 104.91 79.26 56.10 43.20 22.99 Net Block 46.57 38.93 32.34 30.35 30.97 31.35 16.28 20.50 14.51 7.92 Gross Block 62.98 51.54 42.14 37.99 36.61 35.11 25.00 27.93 20.80 13.40 Accumulated Depreciation 16.40 12.61 9.80 7.64 5.64 3.76 8.71 7.43 6.29 5.49 Non Current Assets 50.40 41.07 34.34 31.54 32.05 32.39 27.78 20.85 14.92 9.81 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 11.15 0.00 0.00 1.41 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.36 2.13 2.00 1.18 1.08 1.03 0.35 0.35 0.31 0.48 Other Non Current Assets 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.00 Current Assets 257.20 216.21 152.65 130.08 109.32 72.52 51.48 35.24 28.28 13.08 Current Investments 0.81 0.31 0.06 0.06 0.05 0.00 0.00 0.00 0.00 0.00 Inventories 175.00 150.12 46.46 67.57 50.46 40.78 18.43 6.94 10.27 4.29 Sundry Debtors 64.85 34.56 90.27 41.08 38.97 17.78 15.26 20.38 11.40 5.19 Cash & Bank 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 Other Current Assets 15.20 0.75 0.58 0.36 16.78 12.49 16.35 7.18 5.22 3.00 Short Term Loans & Adv. 13.76 27.03 13.20 19.89 16.49 0.75 7.70 6.31 5.01 1.05 Net Current Assets 90.37 76.55 78.90 43.63 23.33 19.11 -1.56 -5.23 -3.65 -3.14 Total Assets 307.60 257.28 186.99 161.62 141.37 104.91 79.26 56.09 43.20 23.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 PBT 21.45 17.46 8.58 2.01 2.35 6.18 1.75 2.23 1.83 0.52 Adjustment 16.77 11.70 7.82 8.65 6.03 2.08 2.67 2.00 1.74 1.15 Changes in Working Capital -38.66 -43.57 -18.77 -10.50 -19.02 -7.43 12.88 -0.25 -0.25 0.11 Cash after chg. in Working capital -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.64 -9.40 -4.14 -1.39 -1.49 -5.25 -8.21 -7.13 -5.99 -3.00 Net Fixed Assets -11.44 -9.40 -4.15 -1.38 -1.50 1.04 -8.22 -7.13 -5.99 -2.71 Net Investments -0.50 -0.25 0.00 -0.01 -0.05 0.00 0.00 0.00 0.00 0.00 Others 4.30 0.25 0.01 0.00 0.06 -6.29 0.01 0.00 0.00 -0.29 Cash from Financing Activity 5.99 25.18 7.47 -0.71 13.73 4.43 -8.38 2.52 3.45 1.40 Net Cash Inflow / Outflow -2.08 1.36 0.94 -1.93 1.59 0.01 0.70 -0.64 0.79 0.18 Opening Cash & Equivalents 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 0.42 Closing Cash & Equivalent 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 255.15 194.27 153.07 107.96 103.57 97.73 64.71 20.14 15.68 11.50 ROA 5.53% 4.86% 3.63% 1.33% 1.54% 4.84% 2.59% 2.88% 3.23% 1.26% ROE 15.03% 13.86% 11.42% 4.77% 4.74% 14.59% 13.02% 33.88% 33.46% 9.68% ROCE 17.13% 17.64% 13.15% 9.53% 10.36% 20.56% 15.90% 18.16% 24.67% 14.23% Fixed Asset Turnover 6.08 5.86 5.60 3.59 3.14 3.23 2.25 2.33 2.47 1.99 Receivable days 52.11 82.94 106.79 109.11 91.85 62.16 109.23 102.30 71.54 62.01 Inventory Days 170.43 130.61 92.72 160.89 147.66 111.37 77.73 55.39 62.77 56.62 Payable days 85.40 94.41 111.88 189.53 178.44 158.25 217.97 146.17 106.16 100.81 Cash Conversion Cycle 137.13 119.14 87.63 80.47 61.07 15.28 -31.02 11.52 28.15 17.82 Total Debt/Equity 0.88 0.98 0.78 0.92 0.84 0.49 0.45 2.53 3.92 3.06 Interest Cover 2.57 2.89 2.80 1.73 1.56 2.97 2.36 2.19 1.89 1.50

Top Investors:

nikhil kishorchandra vora

harsha venkatesh

arun kumar mukherjee

Annual Reports:

News Update:

Fredun Pharmaceuticals’ arm acquires controlling interest in One Pet Stop
30th Jun 2025, 15:29 PM

The acquisition creates strong synergies with Fredun’s Freossi brand, which offers a premium range of pet grooming products
Read More
Fredun Pharmaceuticals secures tender from TNMSC for supply of generic medicines
10th Apr 2025, 14:35 PM

The total value of the tender ranges between Rs 15 crore and Rs 18 crore
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback